Anti-FOXC2 monoclonal antibody
Pre-made anti-FOXC2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to FOXC2/FOXC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T46092-Ab-1/ GM-Tg-hg-T46092-Ab-2 | Anti-Human FOXC2 monoclonal antibody | Human |
GM-Tg-rg-T46092-Ab-1/ GM-Tg-rg-T46092-Ab-2 | Anti-Rat FOXC2 monoclonal antibody | Rat |
GM-Tg-mg-T46092-Ab-1/ GM-Tg-mg-T46092-Ab-2 | Anti-Mouse FOXC2 monoclonal antibody | Mouse |
GM-Tg-cynog-T46092-Ab-1/ GM-Tg-cynog-T46092-Ab-2 | Anti-Cynomolgus/ Rhesus macaque FOXC2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T46092-Ab-1/ GM-Tg-felg-T46092-Ab-2 | Anti-Feline FOXC2 monoclonal antibody | Feline |
GM-Tg-cang-T46092-Ab-1/ GM-Tg-cang-T46092-Ab-2 | Anti-Canine FOXC2 monoclonal antibody | Canine |
GM-Tg-bovg-T46092-Ab-1/ GM-Tg-bovg-T46092-Ab-2 | Anti-Bovine FOXC2 monoclonal antibody | Bovine |
GM-Tg-equg-T46092-Ab-1/ GM-Tg-equg-T46092-Ab-2 | Anti-Equine FOXC2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T46092-Ab-1/ GM-Tg-hg-T46092-Ab-2; GM-Tg-rg-T46092-Ab-1/ GM-Tg-rg-T46092-Ab-2; GM-Tg-mg-T46092-Ab-1/ GM-Tg-mg-T46092-Ab-2; GM-Tg-cynog-T46092-Ab-1/ GM-Tg-cynog-T46092-Ab-2; GM-Tg-felg-T46092-Ab-1/ GM-Tg-felg-T46092-Ab-2; GM-Tg-cang-T46092-Ab-1/ GM-Tg-cang-T46092-Ab-2; GM-Tg-bovg-T46092-Ab-1/ GM-Tg-bovg-T46092-Ab-2; GM-Tg-equg-T46092-Ab-1/ GM-Tg-equg-T46092-Ab-2 |
Products Name | Anti-FOXC2 monoclonal antibody |
Format | mab |
Target Name | FOXC2 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-FOXC2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-T46092-Ag-1 | Recombinant multi-species FOXC2/ FKHL14/ LD protein |
ORF Viral Vector | pGMAAV000200 | human FOXC2 AAV plasmid |
ORF Viral Vector | vGMAAV000200 | human FOXC2 AAV particle |
ORF Viral Vector | pGMAD000258 | mouse Foxc2 Adenovirus plasmid |
ORF Viral Vector | vGMAD000258 | mouse Foxc2 Adenovirus particle |
Target information
Target ID | GM-T46092 |
Target Name | FOXC2 |
Gene ID | 2303,14234,171356,694852,119863920,111558062,507300,100036555 |
Gene Symbol and Synonyms | Fkh14,FKHL14,FOXC2,Hfhbf3,LD,LOC119863920,MFH-1,MFH1 |
Uniprot Accession | Q99958,Q63246 |
Uniprot Entry Name | FOXC2_HUMAN,FOXC2_RAT |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | Cancer |
Gene Ensembl | ENSG00000176692 |
Target Classification | Tumor-associated antigen (TAA) |
The target: FOXC2, gene name: FOXC2, also named as FKHL14, LD, MFH-1, MFH1. This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it may play a role in the development of mesenchymal tissues. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.